Comparative effect of different corticosteroids in severe community-acquired pneumonia: a network meta-analysis

Abstract Background and objectives Severe community-acquired pneumonia (CAP) is a potentially fatal pulmonary disease. Although studies have investigated the efficacy and safety of corticosteroids for severe CAP, the results remain inconsistent. Moreover, there is a lack of sufficient evidence to ra...

Full description

Saved in:
Bibliographic Details
Main Authors: Liangdong Zhu, Jia Zeng, Hui Li, Keyu Li, Xia Chen
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Pulmonary Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12890-025-03679-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850206449739759616
author Liangdong Zhu
Jia Zeng
Hui Li
Keyu Li
Xia Chen
author_facet Liangdong Zhu
Jia Zeng
Hui Li
Keyu Li
Xia Chen
author_sort Liangdong Zhu
collection DOAJ
description Abstract Background and objectives Severe community-acquired pneumonia (CAP) is a potentially fatal pulmonary disease. Although studies have investigated the efficacy and safety of corticosteroids for severe CAP, the results remain inconsistent. Moreover, there is a lack of sufficient evidence to rank the effects of different types of corticosteroids. The aim of this study is to elucidate the effects of different corticosteroids in patients with severe CAP. Methods We searched PubMed, Embase, Cochrane Library, and Web of Science comprehensively, encompassing all publications with a search deadline of March 31, 2024. Only randomized controlled trials (RCTs) involving the treatment of severe CAP with corticosteroids were included. The primary efficacy outcome was all-cause mortality, secondary efficacy outcome was mechanical ventilation (MV), and safety outcome was the incidence of serious adverse events (SAEs). Results A total of 11 studies, involving 2042 participants, compared four corticosteroids (hydrocortisone, dexamethasone, prednisolone, methylprednisolone). The included trials were all corticosteroid versus placebo comparisons, resulting in a star-shaped network. Among the four corticosteroids, only hydrocortisone was significantly more effective at reducing mortality than placebo (RR, 0.35; 95% CrI, 0.14–0.64). Additionally, hydrocortisone reduced the need for MV (RR, 0.73; 95% CrI, 0.51–0.93). Furthermore, subgroup analysis indicated that low-to-moderate doses, short-course corticosteroids are associated with a reduction in both mortality and the need for MV. Conclusion In the evaluated corticosteroid regimen, hydrocortisone might be an effective measure to reduce all-cause mortality in patients with severe CAP. Clinical trial number The present study is a meta-analysis and literature review, therefore clinical trial number is not applicable.
format Article
id doaj-art-7c4d17bae6324e63b0ec6cbb1b1399e7
institution OA Journals
issn 1471-2466
language English
publishDate 2025-04-01
publisher BMC
record_format Article
series BMC Pulmonary Medicine
spelling doaj-art-7c4d17bae6324e63b0ec6cbb1b1399e72025-08-20T02:10:50ZengBMCBMC Pulmonary Medicine1471-24662025-04-0125111010.1186/s12890-025-03679-wComparative effect of different corticosteroids in severe community-acquired pneumonia: a network meta-analysisLiangdong Zhu0Jia Zeng1Hui Li2Keyu Li3Xia Chen4The First Hospital of ChangshaNational Respiratory Center of the First Affiliated Hospital of Guangzhou Medical UniversityThe First Hospital of ChangshaThe First Hospital of ChangshaThe First Affiliated Hospital of Hunan University of MedicineAbstract Background and objectives Severe community-acquired pneumonia (CAP) is a potentially fatal pulmonary disease. Although studies have investigated the efficacy and safety of corticosteroids for severe CAP, the results remain inconsistent. Moreover, there is a lack of sufficient evidence to rank the effects of different types of corticosteroids. The aim of this study is to elucidate the effects of different corticosteroids in patients with severe CAP. Methods We searched PubMed, Embase, Cochrane Library, and Web of Science comprehensively, encompassing all publications with a search deadline of March 31, 2024. Only randomized controlled trials (RCTs) involving the treatment of severe CAP with corticosteroids were included. The primary efficacy outcome was all-cause mortality, secondary efficacy outcome was mechanical ventilation (MV), and safety outcome was the incidence of serious adverse events (SAEs). Results A total of 11 studies, involving 2042 participants, compared four corticosteroids (hydrocortisone, dexamethasone, prednisolone, methylprednisolone). The included trials were all corticosteroid versus placebo comparisons, resulting in a star-shaped network. Among the four corticosteroids, only hydrocortisone was significantly more effective at reducing mortality than placebo (RR, 0.35; 95% CrI, 0.14–0.64). Additionally, hydrocortisone reduced the need for MV (RR, 0.73; 95% CrI, 0.51–0.93). Furthermore, subgroup analysis indicated that low-to-moderate doses, short-course corticosteroids are associated with a reduction in both mortality and the need for MV. Conclusion In the evaluated corticosteroid regimen, hydrocortisone might be an effective measure to reduce all-cause mortality in patients with severe CAP. Clinical trial number The present study is a meta-analysis and literature review, therefore clinical trial number is not applicable.https://doi.org/10.1186/s12890-025-03679-wHydrocortisonePneumoniaNetwork meta-analysis
spellingShingle Liangdong Zhu
Jia Zeng
Hui Li
Keyu Li
Xia Chen
Comparative effect of different corticosteroids in severe community-acquired pneumonia: a network meta-analysis
BMC Pulmonary Medicine
Hydrocortisone
Pneumonia
Network meta-analysis
title Comparative effect of different corticosteroids in severe community-acquired pneumonia: a network meta-analysis
title_full Comparative effect of different corticosteroids in severe community-acquired pneumonia: a network meta-analysis
title_fullStr Comparative effect of different corticosteroids in severe community-acquired pneumonia: a network meta-analysis
title_full_unstemmed Comparative effect of different corticosteroids in severe community-acquired pneumonia: a network meta-analysis
title_short Comparative effect of different corticosteroids in severe community-acquired pneumonia: a network meta-analysis
title_sort comparative effect of different corticosteroids in severe community acquired pneumonia a network meta analysis
topic Hydrocortisone
Pneumonia
Network meta-analysis
url https://doi.org/10.1186/s12890-025-03679-w
work_keys_str_mv AT liangdongzhu comparativeeffectofdifferentcorticosteroidsinseverecommunityacquiredpneumoniaanetworkmetaanalysis
AT jiazeng comparativeeffectofdifferentcorticosteroidsinseverecommunityacquiredpneumoniaanetworkmetaanalysis
AT huili comparativeeffectofdifferentcorticosteroidsinseverecommunityacquiredpneumoniaanetworkmetaanalysis
AT keyuli comparativeeffectofdifferentcorticosteroidsinseverecommunityacquiredpneumoniaanetworkmetaanalysis
AT xiachen comparativeeffectofdifferentcorticosteroidsinseverecommunityacquiredpneumoniaanetworkmetaanalysis